Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
about
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysisA comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki diseaseAssociation of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.Cancer and Thrombosis: The Platelet Perspective.Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancerElevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival.Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Retrospective study of the prognostic significance of neutrophil-to-lymphocyte ratio for postsurgical outcomes of patients with endometrial carcinoma.Circulating cell-free DNA content as blood based biomarker in endometrial cancer.The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratioCombined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection.Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapyPrognostic value of Systemic immune-inflammation index in cancer: A meta-analysisPrognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study
P2860
Q28067745-6CA8A666-2C11-4DA8-BEB4-1DC8D8610C6BQ33718985-6DB26D70-6085-45D8-BF21-B3A645AECDB0Q36288498-E9D70646-02C6-4794-9D28-9BEADFFDB6E9Q36764919-C32EACD0-0BEB-45BD-8A08-A5168E009252Q37362567-9BAEE29D-194D-48FB-B04F-0551F477D8A1Q37406761-8EB1F650-EF55-4090-B6DE-AB03095F9569Q37558436-072D86D1-6724-46D9-9923-A15C835A05BBQ37657622-0EEAEC6E-A44A-4CDF-9F69-4E3AFE6267E8Q37745835-3D321462-7105-4347-8CF0-E54845ED7762Q38620295-2D336715-FA11-4E54-B33E-17E9856EA55EQ39322836-005543EE-2146-4905-BE0D-E875F205D37AQ39417307-81E25B42-6DB0-4952-AA4A-2ACBDFD7C704Q39479184-340F34C7-A6FC-40B0-9231-DD3AE0E8D3A0Q41092061-B5C15F9F-879E-4BE2-B300-6E9B978311DFQ41777743-79452C92-0311-4DA5-A289-6134DDD81DE8Q47338550-C47286BA-2BCF-476F-A533-92D07811A529Q47350448-CE8DA2E2-027C-4DEA-853C-4DF4D5590DF2Q49172103-B3EA0565-CCE8-4FDA-86C1-22C26C848369Q49301073-F6ABE350-DF59-425E-B196-FCC4991F0531Q51732590-7B403EC6-A043-47F2-8F58-90367D5B37E7Q55118953-106C1157-2480-4459-A46F-2A9C5F60E5CEQ55236680-1F6EE288-3305-4275-A51A-C222ACC9C5C3Q55406159-DF941040-E3AB-4773-920C-7AF3002B75F9Q57070172-E1ABC8E6-7A7D-4E7F-9817-B4A36B14A129Q57116768-8222CFFF-4141-4D60-95DF-D1BC5B50F280Q58770197-63ED446A-E498-4CEB-8003-5BDD001351E5
P2860
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@ast
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en-gb
type
label
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@ast
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en-gb
prefLabel
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@ast
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en
Preoperative neutrophil:lympho ...... t endometrial cancer survival.
@en-gb
P2093
P2860
P356
P1154
2-s2.0-84937074356
P1476
Preoperative neutrophil:lympho ...... ct endometrial cancer survival
@en
P2093
J Sarveswaran
M Cummings
M Grzelinski
P2860
P2888
P304
P356
10.1038/BJC.2015.200
P407
P5530
P577
2015-06-16T00:00:00Z
P5875
P6179
1002473743